                         SEQUENCE LISTING

<110>  PreveCeutical Medical Inc.
 
<120>  Peptides and uses thereof

<130>  P113134.PCT

<160>  58    

<170>  PatentIn version 3.5

<210>  1
<211>  6
<212>  PRT
<213>  synthesised peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa - gamma-aminobutyric acid

<400>  1

Tyr Xaa Phe Leu Arg Arg 
1               5       


<210>  2
<211>  6
<212>  PRT
<213>  synthesised peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa - Sarcosine

<400>  2

Tyr Xaa Phe Leu Arg Arg 
1               5       


<210>  3
<211>  6
<212>  PRT
<213>  synthesised peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa - Sarcosine

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa - DArg

<400>  3

Tyr Xaa Phe Leu Arg Xaa 
1               5       


<210>  4
<211>  6
<212>  PRT
<213>  synthesised peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa - Sarcosine

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa - 2-amino-3-(4-nitrophenyl)propanoic acid

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa - DArg

<400>  4

Tyr Xaa Xaa Leu Arg Xaa 
1               5       


<210>  5
<211>  6
<212>  PRT
<213>  synthesised peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa - Sarcosine

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa - 2-amino-3-(4-nitrophenyl)propanoic acid

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Xaa - DArg

<400>  5

Tyr Xaa Xaa Leu Xaa Arg 
1               5       


<210>  6
<211>  6
<212>  PRT
<213>  synthesised peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa - Sarcosine

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Xaa - DArg

<400>  6

Tyr Xaa Phe Leu Xaa Arg 
1               5       


<210>  7
<211>  6
<212>  PRT
<213>  synthesised peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa - Sarcosine

<220>
<221>  MISC_FEATURE
<222>  (5)..(6)
<223>  Xaa - DArg

<400>  7

Tyr Xaa Phe Leu Xaa Xaa 
1               5       


<210>  8
<211>  6
<212>  PRT
<213>  synthesised peptide


<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa - 2-amino-3-(4-nitrophenyl)propanoic acid

<220>
<221>  MISC_FEATURE
<222>  (5)..(6)
<223>  Xaa - DArg

<400>  8

Tyr Gly Xaa Leu Xaa Xaa 
1               5       


<210>  9
<211>  6
<212>  PRT
<213>  synthesised peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa - Sarcosine

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa - 2-amino-3-(4-nitrophenyl)propanoic acid

<220>
<221>  MISC_FEATURE
<222>  (5)..(6)
<223>  Xaa - DArg

<400>  9

Phe Xaa Xaa Leu Xaa Xaa 
1               5       


<210>  10
<211>  6
<212>  PRT
<213>  synthesised peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa - Sarcosine

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa - 2-amino-3-(4-nitrophenyl)propanoic acid

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Xaa - DLys

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa - DArg

<400>  10

Tyr Xaa Xaa Leu Xaa Xaa 
1               5       


<210>  11
<211>  6
<212>  PRT
<213>  synthesised peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa - Sarcosine

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa - 2-amino-3-(4-chlorophenyl)propanoic acid

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa - DArg

<400>  11

Tyr Xaa Xaa Leu Arg Xaa 
1               5       


<210>  12
<211>  6
<212>  PRT
<213>  synthesised peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa - Sarcosine

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa - 2-amino-3-(4-fluorophenyl)propanoic acid

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa - DArg

<400>  12

Tyr Xaa Xaa Leu Arg Xaa 
1               5       


<210>  13
<211>  6
<212>  PRT
<213>  synthesised peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa - Sarcosine

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa - 2-amino-3-(4-chlorophenyl)propanoic acid

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Xaa - N-methylarginine

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa - DArg

<400>  13

Tyr Xaa Xaa Leu Xaa Xaa 
1               5       


<210>  14
<211>  6
<212>  PRT
<213>  synthesised peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa - Sarcosine

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa - 2-amino-3-(4-fluorophenyl)propanoic acid

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Xaa - N-methylarginine

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa - DArg

<400>  14

Tyr Xaa Xaa Leu Xaa Xaa 
1               5       


<210>  15
<211>  6
<212>  PRT
<213>  synthesised peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa - Sarcosine

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa - 2-amino-3-(4-nitrophenyl)propanoic acid

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Xaa - N-methylarginine

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa - DArg

<400>  15

Tyr Xaa Xaa Leu Xaa Xaa 
1               5       


<210>  16
<211>  6
<212>  PRT
<213>  synthesised peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa - Sarcosine

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa - 2-amino-3-(4-chlorophenyl)propanoic acid

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa - DArg

<400>  16

Tyr Xaa Xaa Leu Lys Xaa 
1               5       


<210>  17
<211>  6
<212>  PRT
<213>  synthesised peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa - Sarcosine

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa - 2-amino-3-(4-chlorophenyl)propanoic acid

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa - N-methylarginine

<400>  17

Tyr Xaa Xaa Leu Arg Xaa 
1               5       


<210>  18
<211>  6
<212>  PRT
<213>  synthesised peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa - Sarcosine

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa - 2-amino-3-(4-nitrophenyl)propanoic acid

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa - N-methylarginine

<400>  18

Tyr Xaa Xaa Leu Arg Xaa 
1               5       


<210>  19
<211>  6
<212>  PRT
<213>  synthesised peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa - Sarcosine

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa - 2-amino-3-(4-nitrophenyl)propanoic acid

<220>
<221>  MISC_FEATURE
<222>  (5)..(6)
<223>  Xaa - N-methylarginine

<400>  19

Tyr Xaa Xaa Leu Xaa Xaa 
1               5       


<210>  20
<211>  8
<212>  PRT
<213>  synthesised peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa - Sarcosine

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa - 2-amino-3-(4-chlorophenyl)propanoic acid

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa - DArg

<400>  20

Tyr Xaa Xaa Leu Arg Xaa Ile Arg 
1               5               


<210>  21
<211>  7
<212>  PRT
<213>  synthesised peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa - Sarcosine

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa - 2-amino-3-(4-chlorophenyl)propanoic acid

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa - DArg

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Xaa - CH2CH2CH2CH2CH2CONH2

<400>  21

Tyr Xaa Xaa Leu Arg Xaa Xaa 
1               5           


<210>  22
<211>  10
<212>  PRT
<213>  synthesised peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa - Sarcosine

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa - 2-amino-3-(4-chlorophenyl)propanoic acid

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa - DArg

<400>  22

Tyr Xaa Xaa Leu Arg Xaa Ile Arg Pro Lys 
1               5                   10  


<210>  23
<211>  10
<212>  PRT
<213>  synthesised peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa - Sarcosine

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa - 2-amino-3-(4-chlorophenyl)propanoic acid

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa - DArg

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  Xaa - DArg

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa - DLys

<400>  23

Tyr Xaa Xaa Leu Arg Xaa Ile Xaa Pro Xaa 
1               5                   10  


<210>  24
<211>  7
<212>  PRT
<213>  synthesised peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa - Sarcosine

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa - 2-amino-3-(4-chlorophenyl)propanoic acid

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa - DArg

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Xaa - CH2CH2CH2CH2CH2CH2CH2CONH2

<400>  24

Tyr Xaa Xaa Leu Arg Xaa Xaa 
1               5           


<210>  25
<211>  8
<212>  PRT
<213>  synthesised peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa - Sarcosine

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa - 2-amino-3-(4-chlorophenyl)propanoic acid

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa - DArg

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  Xaa - DArg

<400>  25

Tyr Xaa Xaa Leu Arg Xaa Ile Xaa 
1               5               


<210>  26
<211>  8
<212>  PRT
<213>  synthesised peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa - Sarcosine

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa - 2-amino-3-(4-chlorophenyl)propanoic acid

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa - N-methylarginine

<400>  26

Tyr Xaa Xaa Leu Arg Xaa Ile Arg 
1               5               


<210>  27
<211>  8
<212>  PRT
<213>  synthesised peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa - Sarcosine

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa - 2-amino-3-(4-nitrophenyl)propanoic acid

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa - N-methylarginine

<400>  27

Tyr Xaa Xaa Leu Arg Xaa Ile Arg 
1               5               


<210>  28
<211>  7
<212>  PRT
<213>  synthesised peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa - Sarcosine

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa - 2-amino-3-(4-chlorophenyl)propanoic acid

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa - DArg

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Xaa - CH2CH2CH2CH2CH2CH2CH2COOH

<400>  28

Tyr Xaa Xaa Leu Arg Xaa Xaa 
1               5           


<210>  29
<211>  7
<212>  PRT
<213>  synthesised peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa - Sarcosine

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa - 2-amino-3-(4-chlorophenyl)propanoic acid

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa - N-methylarginine

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Xaa - CH2CH2CH2CH2CH2CH2CH2CONH2

<400>  29

Tyr Xaa Xaa Leu Arg Xaa Xaa 
1               5           


<210>  30
<211>  7
<212>  PRT
<213>  synthesised peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa - Sarcosine

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa - 2-amino-3-(4-nitrophenyl)propanoic acid

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa - N-methylarginine

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Xaa - CH2CH2CH2CH2CH2CH2CH2CONH2

<400>  30

Tyr Xaa Xaa Leu Arg Xaa Xaa 
1               5           


<210>  31
<211>  7
<212>  PRT
<213>  synthesised peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa - Sarcosine

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa - 2-amino-3-(4-nitrophenyl)propanoic acid

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa - DArg

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Xaa - CH2CH2CH2CH2CH2CH2CH2CONH2

<400>  31

Tyr Xaa Xaa Leu Arg Xaa Xaa 
1               5           


<210>  32
<211>  5
<212>  PRT
<213>  synthesised peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(2)
<223>  Xaa - DPhe

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa - DLeu

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa - DLys

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Xaa - 4,4-carboxyaminopiperidine

<400>  32

Xaa Xaa Xaa Xaa Xaa 
1               5   


<210>  33
<211>  6
<212>  PRT
<213>  synthesised peptide

<400>  33

Phe Phe Leu Gly Arg Arg 
1               5       


<210>  34
<211>  17
<212>  PRT
<213>  Homo sapiens

<400>  34

Tyr Gly Gly Phe Leu Arg Arg Ile Arg Pro Lys Leu Lys Trp Asp Asn 
1               5                   10                  15      


Gln 
    


<210>  35
<211>  7
<212>  PRT
<213>  Homo sapiens

<400>  35

Tyr Gly Gly Phe Leu Arg Arg 
1               5           


<210>  36
<211>  7
<212>  PRT
<213>  synthesised peptide


<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa - 2-amino-3-(4-nitrophenyl)propanoic acid

<400>  36

Tyr Gly Gly Xaa Leu Arg Arg 
1               5           


<210>  37
<211>  7
<212>  PRT
<213>  synthesised peptide


<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa - 2-amino-3-(4-methoxyphenyl)propanoic acid

<400>  37

Tyr Gly Gly Xaa Leu Arg Arg 
1               5           


<210>  38
<211>  7
<212>  PRT
<213>  synthesised peptide


<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa - 2-amino-3-(2-aminophenyl)propanoic acid

<400>  38

Tyr Gly Gly Xaa Leu Arg Arg 
1               5           


<210>  39
<211>  7
<212>  PRT
<213>  synthesised peptide

<400>  39

Tyr Gly Gly Phe Leu Arg His 
1               5           


<210>  40
<211>  7
<212>  PRT
<213>  synthesised peptide

<400>  40

Tyr Gly Gly Phe Leu Arg Asn 
1               5           


<210>  41
<211>  7
<212>  PRT
<213>  synthesised peptide


<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Xaa - 4,4-carboxyaminopiperidine

<400>  41

Tyr Gly Gly Phe Leu Arg Xaa 
1               5           


<210>  42
<211>  7
<212>  PRT
<213>  synthesised peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa - 2-methylamino-3-(4-methoxyphenyl)propanoic acid

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Xaa - 4,4-carboxyaminopiperidine

<400>  42

Xaa Gly Gly Phe Leu Arg Xaa 
1               5           


<210>  43
<211>  7
<212>  PRT
<213>  synthesised peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa - 2-methylamino-3-(4-methoxyphenyl)propanoic acid

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Xaa - 4,4-carboxyaminopiperidine

<400>  43

Xaa Gly Gly Phe Leu Lys Xaa 
1               5           


<210>  44
<211>  7
<212>  PRT
<213>  synthesised peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa - 3-(4-pyridyl)alanine

<400>  44

Xaa Gly Gly Phe Leu Arg Arg 
1               5           


<210>  45
<211>  7
<212>  PRT
<213>  synthesised peptide


<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa - Citrulline

<400>  45

Tyr Gly Gly Phe Leu Xaa Arg 
1               5           


<210>  46
<211>  7
<212>  PRT
<213>  synthesised peptide

<400>  46

Tyr Gly Gly Phe Leu Asn Arg 
1               5           


<210>  47
<211>  7
<212>  PRT
<213>  synthesised peptide


<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa - DAla

<400>  47

Tyr Gly Xaa Phe Leu Arg Arg 
1               5           


<210>  48
<211>  7
<212>  PRT
<213>  synthesised peptide


<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa - 2-thienylalanine

<400>  48

Tyr Gly Gly Xaa Leu Asn Arg 
1               5           


<210>  49
<211>  7
<212>  PRT
<213>  synthesised peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa - 2-methylamino-3-(4-methoxyphenyl)propanoic acid

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa - Sarcosine

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Xaa - 4,4-carboxyaminopiperidine

<400>  49

Xaa Xaa Gly Phe Leu Arg Xaa 
1               5           


<210>  50
<211>  7
<212>  PRT
<213>  synthesised peptide


<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Xaa - 4,4-carboxyaminopiperidine

<400>  50

Tyr Gly Gly Phe Leu Lys Xaa 
1               5           


<210>  51
<211>  7
<212>  PRT
<213>  synthesised peptide


<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Xaa - homoarginine

<400>  51

Tyr Gly Gly Phe Leu Arg Xaa 
1               5           


<210>  52
<211>  7
<212>  PRT
<213>  synthesised peptide


<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa - 2-amino-3-(4-nitrophenyl)propanoic acid

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Xaa - DArg

<400>  52

Tyr Gly Gly Xaa Leu Arg Xaa 
1               5           


<210>  53
<211>  7
<212>  PRT
<213>  synthesised peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa - Sarcosine

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa - 2-amino-3-(4-nitrophenyl)propanoic acid

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Xaa - DArg

<400>  53

Tyr Xaa Gly Xaa Leu Arg Xaa 
1               5           


<210>  54
<211>  7
<212>  PRT
<213>  synthesised peptide


<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa - Sarcosine

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa - 2-amino-3-(4-nitrophenyl)propanoic acid

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Xaa - DArg

<400>  54

Tyr Gly Xaa Xaa Leu Arg Xaa 
1               5           


<210>  55
<211>  7
<212>  PRT
<213>  synthesised peptide


<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa - Sarcosine

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa - 2-amino-3-(4-nitrophenyl)propanoic acid

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa - DArg

<400>  55

Tyr Gly Xaa Xaa Leu Xaa Arg 
1               5           


<210>  56
<211>  7
<212>  PRT
<213>  synthesised peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa - Sarcosine

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa - 2-amino-3-(4-nitrophenyl)propanoic acid

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa - DArg

<400>  56

Tyr Xaa Gly Xaa Leu Xaa Arg 
1               5           


<210>  57
<211>  7
<212>  PRT
<213>  synthesised peptide


<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa - 2-amino-3-(4-nitrophenyl)propanoic acid

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa - DArg

<400>  57

Tyr Gly Gly Xaa Leu Xaa Arg 
1               5           


<210>  58
<211>  7
<212>  PRT
<213>  synthesised peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa - Sarcosine

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa - 2-amino-3-(4-nitrophenyl)propanoic acid

<220>
<221>  MISC_FEATURE
<222>  (6)..(7)
<223>  Xaa - DArg

<400>  58

Tyr Xaa Gly Xaa Leu Xaa Xaa 
1               5           


